Published in Hepatitis Weekly, February 23rd, 2004
MedMira has confidence that this move will open up a new region with great potential for its global health technology.
The MiraWell Triple Test is based on MedMira's technology platform, a one-of-a-kind diagnostic test for the simultaneous detection of antibodies to HIV, hepatitis B, and hepatitis C.
"We've...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2004-02-23)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.